Labosuan R&D is the pharmaceutical laboratory of SUANFARMA Group. Its main activity is the development of generic medicines for the Industry to be commercialized by third laboratories in any part of the world. Labosuans developments are based duly on SUANFARMA active principles and also coming from other sources.

Labosuan commercialize its products through licensing and supply agreements although there are some other business models to be used with its partners depending on clients needs.


Development of finished pharmaceutical products in all pharmaceutical forms, including injectables.

  • Generic drug products
  • OTC´s
  • Nutritional Supplements
  • Biosimilars

Licensing and supply: in Labosuan we do not commercialize our products directly but we license and supply finished product for laboratories.

Sale of dossiers: we sell our own dossiers free of supply to manufacturer labs.

Technological transfers: we offer support to laboratories that obtain our dossiers for their implementation in their facilities.

Regulatory services: we offer regulatory support to the laboratories that obtain our dossiers for authorization in their markets.

We continually work for the development of different dossiers, so that in the future, we can register them in different countries and attain marketing authorizations.

Technical support for attaining marketing authorizations.


  • Anticancer
· Anastrozole Tablets 1 mg
· Capecitabine Tablets 150/500 mg
· Docetaxel Concentrate for solution for infusion 20/80/160 mg (20 mg/ml)
· Doxorubicin (pegilated liposomes) Concentrate for solution for infusion 20 mg (2 mg/ml)
· Imatinib Capsules 100/400 mg
· Letrozole Tablets 2,5 mg
· Oxaliplatin Concentrate for solution for infusion 50/100/200 mg
· Paclitaxel Concentrate for solution for infusion 30/100/150/300 mg (6 mg/ml)


Desarrollo de dosieres

  • Hypertension
  • Anti-Alzheimer
  • Other
· Irbesartan Tablets 75/150/300 mg
· Telmisartan Tablets 20/40/80 mg
· Donepezil Tablets 5/10 mg
· Rivastigmine Capsules 1,5/3/4,5/6 mg
· Rivastigmine Solution oral 2 mg/ml
· Claritromicina Lyophilized for injection 500 mg/vial
· Colistimethate Lyophilized for injection 1/2 MUI/vial
· Pantoprazol Lyophilized for injection 40 mg/vial
· Quetiapine Immediate release tablets 25/50/100/150/200/ 300/400 mg
· Quetiapine Slow release tablets 50/150/200/300/ 400 mg

Labosuan doesn’t market directly its developments, but offers them to local laboratories through license and supply agreements, or in specific cases, with tech transfer agreements.

Compléments Alimentaires


  • IRONGEST (Pregnant woman + Fetus)
  • IRONLACT (Lactating mother + Lactating baby)
  • IRONKID (Kid)

DHA, Iron*, Vitamins B2, B6, B9, B12, D, E, Zinc, Manganese, Iodine. 15/30 soft gelatin capsules.

DHA, Iron*, Vitamins A, B1, B2, B3, B6, B9, C, D, E, Zinc, Magnesium, Iodine. 15/30 soft gelatin capsules.

DHA, Iron*, Vitamins A, D, E, Iodine. Only suspension in drops 16.8 ml.

*AB Fortis ®, patented microencapsulated iron. Enhances the tolerance of the final product and provides an effective and taste masking to eliminate its metallic taste.